EULAR recommendation for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Smolen, J ✉; Landewe, R; Bijlsma, J; Burmester, G; Chatzidionysiou, K; Dougados, M; Nam, J; Ramiro, S; Voshaar, M; van Vollenhoven, R; Aletaha, D; Aringer, M; Boers, M; Buckley, CD; Buttgereit, F; Bykerk, V; Cardiel, M; Combe, B; Cutolo, M; van Eijk-Hustings, Y; Emery, P; Finckh, A; Gabay, C; Gomez-Reino, J; Gossec, L; Gottenberg, JE; Hazes, JMW; Huizinga, T; Jani, M; Karateev, D; Kouloumas, M; Kvien, T; Li, ZG; Mariette, X; McInnes, I; Mysler, E; Nash, P; Pavelka, K; Poor, G [Poór, Gyula (Reumatológia, ost...), author] Semmelweis University; Richez, C; van Riel, P; Rubbert-Roth, A; Saag, K; da Silva, J; Stamm, T; Takeuchi, T; Westhovens, R; de Wit, M; van der Heijde, D